0001384101-19-000036.txt : 20190412 0001384101-19-000036.hdr.sgml : 20190412 20190412165114 ACCESSION NUMBER: 0001384101-19-000036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190411 FILED AS OF DATE: 20190412 DATE AS OF CHANGE: 20190412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hall Christopher M CENTRAL INDEX KEY: 0001449535 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36156 FILM NUMBER: 19746838 MAIL ADDRESS: STREET 1: 1401 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERACYTE, INC. CENTRAL INDEX KEY: 0001384101 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 205455398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 243-6300 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: CALDEROME INC DATE OF NAME CHANGE: 20061219 4 1 wf-form4_155510225985847.xml FORM 4 X0306 4 2019-04-11 0 0001384101 VERACYTE, INC. VCYT 0001449535 Hall Christopher M 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 President and COO Common Stock 2019-04-11 4 M 0 17927 2.68 A 46641 D Common Stock 2019-04-11 4 M 0 43017 4 A 89658 D Common Stock 2019-04-11 4 M 0 19056 5.98 A 108714 D Common Stock 2019-04-11 4 S 0 75164 25.0916 D 33550 D Common Stock 2019-04-11 4 S 0 4836 25.5787 D 28714 D Stock Option (right to buy) 2.68 2019-04-11 4 M 0 17927 0 D 2022-03-09 Common Stock 17927.0 0 D Stock Option (right to buy) 4.0 2019-04-11 4 M 0 43017 0 D 2023-02-04 Common Stock 43017.0 0 D Stock Option (right to buy) 5.98 2019-04-11 4 M 0 19056 0 D 2028-03-01 Common Stock 19056.0 91194 D The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. Represents weighted average sales price. Sale prices for the transactions range from $24.55 to $25.54. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Represents weighted average sales price. Sale prices for the transactions range from $25.55 to $25.60. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. The option is fully vested. The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. /s/ Keith Kennedy, as Attorney-in-fact 2019-04-12